NO RELATED MODULATION OF CARDIAC CALCIUM CHANNELS

心脏钙通道无相关调节

• 批准号: 2621695
• 负责人: DONALD Leroy CAMPBELL
• 金额: $ 2.29万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-07-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2621695
• 关键词: calcium channel; ferrets; guanylate cyclase; heart cell; intracellular transport; muscle cells; myocardium; neuromuscular transmission; nitric oxide; oxidation reduction reaction; protein localization; sarcolemma; thiols; tissue /cell culture; voltage /patch clamp

DESCRIPTION (adapted from the applicant's abstract): The general hypotheses to be tested are: 1) NO and RSNOs/OONO- (exemplary protein thiol NO+donating and oxidizing agents, respectively) can modulate L-type calcium current (IcaL) by two distinct mechanisms: i) an indirect mechanism involving activation of soluble guanylyl cyclase (NO); and ii) a direct mechanism involving either S-nitrosylation (RSNOs) or oxidation (RSNOs/OONO-) of critical thiol groups in sarcolemmal and/or extracellularly accessible "redox switches" located either in the L-channel subunit complex or an associated regulatory molecule(s); 2) Specific cellular mechanisms underlying these effects may vary significantly among different cardiac myocyte types (working versus pacemaking myocytes); and 3) Cellular redox state of critical thiols located in the sarcolemmal/ extracellular redox switches is an important determinant in both modulation of cardiac ICaL and in the response "NO". These issues will be addressed using a combination of patch clamp techniques (both whole cell and single channel) to study native IcaL in ferret enzymatically isolated myocytes (ventricle, SA node) and molecular biological techniques (immunolocalization, in situ hybridization) to determine the tissue, cellular and subcellular correlates underlying the functional effects of NO- and redox-related modulation of IcaL.

描述（改编自申请人的摘要）：一般假设 1）NO和RSNO/OONO-（示例性的蛋白硫醇 NO+供体和氧化剂）可以调节L-型钙 电流（IcaL）通过两种不同的机制：i）间接机制 涉及可溶性鸟苷酸环化酶（NO）的活化;和ii）直接 涉及S-亚硝基化（RSNOs）或氧化的机制 （RSNO/OONO-）的关键巯基在肌膜和/或细胞外 可接近的“氧化还原开关”位于L-通道亚基复合物中， 或相关的调节分子; 2）特异性细胞机制 潜在的这些影响可能在不同的心脏之间有很大差异 肌细胞类型（工作肌细胞与起搏肌细胞）;和3）细胞氧化还原 位于肌膜/细胞外氧化还原中的临界巯基状态 开关是心脏ICaL调节和 答案是“不”。 这些问题将通过以下方法加以解决： 膜片钳技术（全细胞和单通道）研究天然的 雪貂酶促分离的肌细胞（心室，SA结）中的IcaL和 分子生物学技术（免疫定位、原位杂交） 以确定组织、细胞和亚细胞相关性， IcaL的NO和氧化还原相关调节的功能效应。